Steven L. Krill, EVP & Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 10,000 shares at $73.62 ($736K) on 2016-12-13, disclosed to the SEC on 2016-12-15.
Open-market sale of $736k EGRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EGRX | SELL | 2016-12-02 | $479K | — | Filing → |
| EGRX | SELL | 2015-06-18 | $814K | — | Filing → |